Back
Aurinia Pharmaceuticals Quote, Financials, Valuation and Earnings
Sell
46
AUPH
Aurinia Pharmaceuticals
Last Price:
5.79
Seasonality Move:
0.65%
7 Day Trial
ALL ACCESS PASS
$
7
Aurinia Pharmaceuticals Price Quote
$5.79
+0.03 (+0.52%)
(Updated: May 20, 2024 at 5:00 PM ET)
Aurinia Pharmaceuticals Key Stats
Sell
46
Aurinia Pharmaceuticals (AUPH)
is a Sell
Day range:
$5.65 - $5.83
52-week range:
$4.71 - $12.43
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
4.69
P/B ratio:
2.18%
Volume:
2.3M
Avg. volume:
1.4M
1-year change:
-46.22%
Market cap:
$823.8M
Revenue:
$175.5M
EPS:
$-0.53
How Much Does Aurinia Pharmaceuticals Make?
-
How Much Are Aurinia Pharmaceuticals's Sales Annually?
AUPH Revenues are $175.5M -
How Much Profit Does Aurinia Pharmaceuticals's Make A Year?
AUPH net income is -$78M
Is Aurinia Pharmaceuticals Growing As A Company?
-
What Is Aurinia Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.59% -
What Is Aurinia Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Aurinia Pharmaceuticals Stock Price Performance
-
Did Aurinia Pharmaceuticals Stock Go Up Last Month?
Aurinia Pharmaceuticals share price went up by 17.31% last month -
Did AUPH's Share Price Rise Over The Last Year?
AUPH share price fell by -46.22% over the past 1 year
What Is Aurinia Pharmaceuticals 52-Week High & Low?
-
What Is Aurinia Pharmaceuticals’s 52-Week High Share Price?
Aurinia Pharmaceuticals has traded as high as $12.43 over the past 52 weeks -
What Is Aurinia Pharmaceuticals’s 52-Week Low Share Price?
Aurinia Pharmaceuticals has traded as low as $4.71 over the past 52 weeks
Aurinia Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Aurinia Pharmaceuticals?
-
How Much Debt Does Aurinia Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does Aurinia Pharmaceuticals Have?
Cash and short term investments quarterly total is $350.5M -
What Is Aurinia Pharmaceuticals’s Book Value Per Share?
Book value per share is 2.63
Is Aurinia Pharmaceuticals Cash Flow Positive?
-
What Is AUPH Cash Flow From Operations?
Cash flow from operations (TTM) is -$33.5M -
What Is Aurinia Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$5.1M -
What Is Aurinia Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$6.7M
Aurinia Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
AUPH return on invested capital is -19.92% -
What Is Aurinia Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -15.15% -
What Is AUPH Return On Equity?
ROE is a measure of profitability and is -19.92%
Aurinia Pharmaceuticals Earnings Date & Stock Price
-
What Is Aurinia Pharmaceuticals's Stock Price Today?
A single share of AUPH can be purchased today for 5.76 -
What Is Aurinia Pharmaceuticals’s Stock Symbol?
Aurinia Pharmaceuticals trades on the nasdaq under the ticker symbol: AUPH -
When Is Aurinia Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Aurinia Pharmaceuticals is scheduled on August 2, 2024 -
When Is AUPH's next ex-dividend date?
Aurinia Pharmaceuticals's next ex-dividend date is July 16, 2020 -
How To Buy Aurinia Pharmaceuticals Stock?
You can buy Aurinia Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Aurinia Pharmaceuticals Competitors
-
Who Are Aurinia Pharmaceuticals's Competitors?
Below is a list of companies who compete with Aurinia Pharmaceuticals or are related in some way:
Aurinia Pharmaceuticals Dividend Yield
Data Unavailable
Aurinia Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 48.78% |
| Revenue: | 58.59% | 6.86% |
Analyst Recommendations
| Buy Recommendations: | 3 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 10.14 |
| Upside from Last Price: | 76.09% |